|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1450 AUD | +7.41% |
|
-3.33% | -3.33% |
Company Valuation: Amplia Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 16.49 | 27.16 | 120.6 | 74.43 | - |
| Change | - | - | 343.99% | -38.27% | - |
| Enterprise Value (EV) 1 | 16.49 | 27.16 | 92.72 | 58.93 | 52.93 |
| Change | - | - | 241.42% | -36.44% | -10.18% |
| P/E | -2.64x | -3.27x | -14.3x | -6.3x | -24.2x |
| PBR | - | - | - | - | - |
| PEG | - | - | 0.6x | -0.2x | 0.3x |
| Capitalization / Revenue | - | - | - | - | 7.44x |
| EV / Revenue | - | - | - | - | 5.29x |
| EV / EBITDA | - | - | -11.2x | -5.12x | -15.1x |
| EV / EBIT | - | - | -11.1x | -5.08x | -14.7x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -0.0322 | -0.0214 | -0.0164 | -0.023 | -0.006 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 10 |
| EBITDA 1 | - | - | -8.297 | -11.5 | -3.5 |
| EBIT 1 | - | - | -8.389 | -11.6 | -3.6 |
| Net income 1 | -6.242 | -6.572 | -7.707 | -11.6 | -3.6 |
| Net Debt 1 | - | - | -27.85 | -15.5 | -21.5 |
| Reference price 2 | 0.0850 | 0.0700 | 0.2350 | 0.1450 | 0.1450 |
| Nbr of stocks (in thousands) | 194,006 | 387,953 | 513,072 | 513,312 | - |
| Announcement Date | 30/05/23 | 30/05/25 | 29/05/26 | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.3x | - | -5.12x | - | 51.77M | |
| 32.72x | 8.29x | 25.68x | 0.06% | 54.63B | |
| 20.57x | 6.35x | 13.84x | 1.56% | 54.88B | |
| -44.31x | 14.51x | -42.32x | -.--% | 25.06B | |
| -18.2x | 4.33x | -7.58x | -.--% | 23.14B | |
| 25x | 4.91x | 12.91x | -.--% | 19.88B | |
| 24.48x | 4.79x | 15.58x | -.--% | 17.55B | |
| 49.34x | 20.07x | 51.69x | 0.07% | 16.5B | |
| 17.75x | 5.16x | 12.01x | -.--% | 14.2B | |
| -539.24x | 37.03x | -4128.99x | -.--% | 15.36B | |
| Average | -43.82x | 11.72x | -405.23x | 0.19% | 24.13B | |
| Weighted average by Cap. | -20.34x | 10.03x | -252.65x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATX Stock
- Valuation Amplia Therapeutics Limited
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
